In an opinion reducing punitive damages awarded to a breast cancer survivor by almost $70 million, Senior Judge Norman Ackerman has become the first Philadelphia Common Pleas Court judge to uphold a jury finding that drugmaker Wyeth failed to warn a plaintiff's prescribing physician of the dangers of breast cancer from using Wyeth's hormone therapy drugs. Both the plaintiff and the defendant in the case could claim wins and losses from Ackerman's opinion.
February 03, 2010 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
In an opinion reducing punitive damages awarded to a breast cancer survivor by almost $70 million, Senior Judge Norman Ackerman has become the first Philadelphia Common Pleas Court judge to uphold a jury finding that drugmaker Wyeth failed to warn a plaintiff’s prescribing physician of the dangers of breast cancer from using Wyeth’s hormonal drugs.
A Philadelphia jury awarded $75 million in punitive damages and $3.7 million in compensatory damages last fall in Barton v. Wyeth.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
